The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.
HSP90 and the chaperoning of cancer
Abstract
Standing watch over the proteome, molecular chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival. This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution. Pharmacologically 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HSP90AB1 is commonly overexpressed in a variety of cancers, with this upregulation typically linked to poor prognostic outcomes and increased resistance to standard chemotherapy and radiotherapy treatments [12, 42, 43].”
From Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer (2024) · cites this paper as [43]
In the citing paper
“This role as a potentiator for genetic variation has been observed in fungi as well as mammalian cancer cells20,88,135,136.”
From Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs (2012) · cites this paper as [88]
In the citing paper
“Second, Hsp90 can enable the phenotypic effects of new mutations either by stabilizing mutant regulators or by stabilizing non-mutant regulators that mediate signalling required for adaptation.”
From Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs (2012) · cites this paper as [88]
Citations
Cites
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Self-citationWhitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Self-citationA high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Hsp90 as a capacitor of phenotypic variation
Queitsch, C., Sangster, T. A., & Lindquist, S. (2002) · Nature · doi:10.1038/nature749 · Cited by 1,372
Self-citationStebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Structure of TPR Domain–Peptide Complexes
Scheufler, C., Brinker, A., Bourenkov, G., Pegoraro, S., Moroder, L., Bartunik, H., Hartl, F. U., & Moarefi, I. (2000) · Cell · doi:10.1016/s0092-8674(00)80830-2 · Cited by 1,188
Role of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell Death
Jolly, C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1564 · Cited by 1,048
The 90-kDa Molecular Chaperone Family
Csermely, P., Schnaider, T., So″ti, C., Prohászka, Z., & Nardai, G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00013-8 · Cited by 1,028
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Role of the Human Heat Shock Protein hsp70 in Protection against Stress-Induced Apoptosis
Mosser, D. D., Caron, A. W., Bourget, L., Denis-Larose, C., & Massie, B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5317 · Cited by 952
Zhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819
Reduced levels of hsp90 compromise steroid receptor action in vivo
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S., & Yamamoto, K. R. (1990) · Nature · doi:10.1038/348166a0 · Cited by 787 · cited 1×
“Chaperones also participate in many higher-order functions, such as the post-translational regulation of signalling molecules, the assembly/disassembly of transcriptional complexe”
BackgroundSelf-citationGHKL, an emergent ATPase/kinase superfamily
DUTTA, R., & INOUYE, M. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01503-0 · Cited by 762
The Chaperone Function of hsp70 Is Required for Protection against Stress-Induced Apoptosis
Mosser, D. D., Caron, A. W., Bourget, L., Meriin, A. B., Sherman, M. Y., Morimoto, R. I., & Massie, B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7146-7159.2000 · Cited by 731
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
Isaacs, J. S., Jung, Y.-J., Mimnaugh, E. G., Martinez, A., Cuttitta, F., & Neckers, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204733200 · Cited by 663
Stress–inducible responses and heat shock proteins: New pharmacologic targets for cytoprotection
Morimoto, R. I., & Santoro, M. G. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-833 · Cited by 632
Hsp90 & Co. – a holding for folding
Buchner, J. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01373-0 · Cited by 628
Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., & Rosen, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206322200 · Cited by 628
Hsp90 isoforms: functions, expression and clinical importance
Subbarao Sreedhar, A., Kalmár, É., Csermely, P., & Shen, Y.-F. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00229-7 · Cited by 620
Escaping Cell Death: Survival Proteins in Cancer
Jäättelä, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4455 · Cited by 611
Apoptosis and the Dilemma of Cancer Chemotherapy
Hannun, Y. A. (1997) · Blood · doi:10.1182/blood.v89.6.1845 · Cited by 605
Hsp70 and Hsp90—a relay team for protein folding
Wegele, H., Müller, L., & Buchner, J. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0021-1 · Cited by 605
Eustace, B. K., Sakurai, T., Stewart, J. K., Yimlamai, D., Unger, C., Zehetmeier, C., Lain, B., Torella, C., Henning, S. W., Beste, G., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1131 · Cited by 590
Proteasome Inhibition As a Novel Therapeutic Target in Human Cancer
Rajkumar, S. V., Richardson, P. G., Hideshima, T., & Anderson, K. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.030 · Cited by 569
Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1
Panaretou, B., Siligardi, G., Meyer, P., Maloney, A., Sullivan, J. K., Singh, S., Millson, S. H., Clarke, P. A., Naaby-Hansen, S., Stein, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00785-2 · Cited by 542
Functional requirement of p23 and Hsp90 in telomerase complexes
Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., et al. (1999) · Genes & Development · doi:10.1101/gad.13.7.817 · Cited by 539
Molecular chaperones and the stress of oncogenesis
Mosser, D. D., & Morimoto, R. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207529 · Cited by 502
Marcu, M. G., Chadli, A., Bouhouche, I., Catelli, M., & Neckers, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003701200 · Cited by 502
Meyer, P., Prodromou, C., Hu, B., Vaughan, C., Roe, S. M., Panaretou, B., Piper, P. W., & Pearl, L. H. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00065-0 · Cited by 491
Banerji, U., O'Donnell, A., Scurr, M., Pacey, S., Stapleton, S., Asad, Y., Simmons, L., Maloney, A., Raynaud, F., Campbell, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.612 · Cited by 488
Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4
Stepanova, L., Leng, X., Parker, S. B., & Harper, J. W. (1996) · Genes & Development · doi:10.1101/gad.10.12.1491 · Cited by 483
Heat-shock proteins as regulators of apoptosis
Takayama, S., Reed, J. C., & Homma, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207114 · Cited by 472
LeBlanc, R., Catley, L. P., Hideshima, T., Lentzsch, S., Mitsiades, C. S., Mitsiades, N., Neuberg, D. S., Goloubeva, O. G., Pien, C. S., Adams, J., et al. (2002) · PubMed · Cited by 450
Pratt, W. B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44252 · Cited by 447
Sittler, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1307 · Cited by 442 · cited 1×
“and protein aggregation disorders such as Huntington disease and Parkinson diseas”
BackgroundSolit, D. B., Zheng, F. F., Drobnjak, M., Münster, P. N., Higgins, B., Verbel, D., Heller, G., Tong, W. P., Cordon‐Cardo, C., Agus, D. B., et al. (2002) · PubMed · Cited by 433
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu
Xu, W., Marcu, M., Yuan, X., Mimnaugh, E., Patterson, C., & Neckers, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202365899 · Cited by 433
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones
Prodromou, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.754 · Cited by 425
Mutational Analysis of Hsp90 Function: Interactions with a Steroid Receptor and a Protein Kinase
Nathan, D. F., & Lindquist, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3917 · Cited by 423
Self-citationHeat-shock protein hsp90 governs the activity of pp60v-src kinase.
Xu, Y., & Lindquist, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7074 · Cited by 416 · cited 1×
“Using genetic and pharmacological approaches, this aberrant chaperone interaction was eventually shown to be essential for both acquisition and maintenance of the increased kinase activity that underlies the transforming activity of v-SR”
BackgroundSelf-citationMembers of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms
Rohde, M., Daugaard, M., Jensen, M. H., Helin, K., Nylandsted, J., & Jäättelä, M. (2005) · Genes & Development · doi:10.1101/gad.305405 · Cited by 413
Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution
Sollars, V., Lu, X., Xiao, L., Wang, X., Garfinkel, M. D., & Ruden, D. M. (2003) · Nature Genetics · doi:10.1038/ng1067 · Cited by 409
Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent Signaling Proteins
Marcu, M. G., Schulte, T. W., & Neckers, L. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.242 · Cited by 405
Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones
Freeman, B. C., & Yamamoto, K. R. (2002) · Science · doi:10.1126/science.1073051 · Cited by 400
TNF-Induced Recruitment and Activation of the IKK Complex Require Cdc37 and Hsp90
Chen, G., Cao, P., & Goeddel, D. V. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00450-1 · Cited by 400
Nylandsted, J., Rohde, M., Brand, K., Bastholm, L., Elling, F., & Jäättelä, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7871 · Cited by 393
In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone
Nathan, D. F., Vos, M. H., & Lindquist, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12949 · Cited by 364
Self-citationModulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228
Yu, X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.504 · Cited by 360
Ciocca, D. R., Clark, G. M., Tandon, A. K., Fuqua, S. A. W., Welch, W. J., & McGuire, W. L. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.7.570 · Cited by 353
Kelland, L. R., Sharp, S. Y., Rogers, P. M., Myers, T. G., & Workman, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1940 · Cited by 350
The Mechanism of Hsp90 Regulation by the Protein Kinase-Specific Cochaperone p50cdc37
Roe, S. M., Ali, M. M. U., Meyer, P., Vaughan, C. K., Panaretou, B., Piper, P. W., Prodromou, C., & Pearl, L. H. (2004) · Cell · doi:10.1016/s0092-8674(03)01027-4 · Cited by 349
Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer
Goetz, M. P., Toft, D., Reid, J., Ames, M., Stensgard, B., Safgren, S., Adjei, A. A., Sloan, J., Atherton, P., Vasile, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.119 · Cited by 336
Birnby, D. A., Link, E. M., Vowels, J. J., Tian, H., Colacurcio, P. L., & Thomas, J. H. (2000) · Genetics · doi:10.1093/genetics/155.1.85 · Cited by 328
Hostein, I., Robertson, D. M., Di-Stefano, F., Workman, P., & Clarke, P. A. (2001) · PubMed · Cited by 320
An evolutionary model of carcinogenesis.
Gatenby, R. A., & Vincent, T. L. (2003) · PubMed · Cited by 318
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.
Blagosklonny, M. V., Toretsky, J., Bohen, S., & Neckers, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8379 · Cited by 314
Altered Hsp90 function in cancer: A unique therapeutic opportunity
Bagatell, R., & Whitesell, L. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1021.3.8 · Cited by 302
Self-citationBetween genotype and phenotype: protein chaperones and evolvability
Rutherford, S. L. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1041 · Cited by 301
Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery
Meyer, P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600141 · Cited by 291
Progesterone Receptor Structure and Function Altered by Geldanamycin, an hsp90-Binding Agent
Smith, D. F., Whitesell, L., Nair, S. C., Chen, S., Prapapanich, V., & Rimerman, R. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6804 · Cited by 289
Self-citationTherapeutic and diagnostic implications of Hsp90 activation
Kamal, A., Boehm, M. F., & Burrows, F. J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.006 · Cited by 278
Solit, D. B., Basso, A. D., Olshen, A. B., Scher, H. I., & Rosen, N. X. (2003) · PubMed · Cited by 277
Bagatell, R., Paine-Murrieta, G. D., Taylor, C. W., Pulcini, E. J., Akinaga, S., Benjamin, I. J., & Whitesell, L. J. (2000) · PubMed · Cited by 269
Self-citationSchulte, T. W., Blagosklonny, M. V., Romanova, L., Mushinski, J. F., Monia, B. P., Johnston, J. F., Nguyen, P., Trepel, J., & Neckers, L. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5839 · Cited by 269
Basso, A. D., Solit, D. B., Munster, P. N., & Rosen, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205184 · Cited by 265
Structure and Functional Relationships of Hsp90
Prodromou, C., & Pearl, L. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481877 · Cited by 261
Under cover: causes, effects and implications of Hsp90‐mediated genetic capacitance
Sangster, T. A., Lindquist, S., & Queitsch, C. (2004) · BioEssays · doi:10.1002/bies.20020 · Cited by 251
Self-citationHsp90 and Cdc37 – a chaperone cancer conspiracy
Pearl, L. H. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.011 · Cited by 242
Grem, J. L., Morrison, G., Guo, X.-D., Agnew, E., Takimoto, C. H., Thomas, R., Szabo, E., Grochow, L., Grollman, F., Hamilton, J. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.085 · Cited by 242
Oppermann, H., Levinson, W., & Bishop, J. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.1067 · Cited by 239
Gorre, M. E., Ellwood-Yen, K., Chiosis, G., Rosen, N., & Sawyers, C. L. (2002) · Blood · doi:10.1182/blood-2002-05-1361 · Cited by 227
A Nucleotide-dependent Molecular Switch Controls ATP Binding at the C-terminal Domain of Hsp90
Söti, C., Rácz, A., & Csermely, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105568200 · Cited by 212
Mimnaugh, E. G., Xu, W., Vos, M., Yuan, X., Isaacs, J. S., Bisht, K. S., Gius, D., & Neckers, L. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.551.3.5 · Cited by 210
Whitesell, L., Sutphin, P. D., Pulcini, E. J., Martinez, J. D., & Cook, P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1517 · Cited by 206
Self-citationMechanisms of Suppression of α-Synuclein Neurotoxicity by Geldanamycin in Drosophila
Auluck, P. K., Meulener, M. C., & Bonini, N. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412106200 · Cited by 203
Structure, function, and mechanism of the Hsp90 molecular chaperone
Pearl, L. H., & Prodromou, C. (2001) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(01)59005-1 · Cited by 201
Harris, S. F., Shiau, A. K., & Agard, D. A. (2004) · Structure · doi:10.1016/j.str.2004.03.020 · Cited by 200
High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity
Rowlands, M. G., Newbatt, Y. M., Prodromou, C., Pearl, L. H., Workman, P., & Aherne, W. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.10.038 · Cited by 199
Molecular Chaperones: Biology and Prospects for Pharmacological Intervention
Smith, D. F., Whitesell, L., & Katsanis, E. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01380-2 · Cited by 198
Self-citationChiosis, G., Lucas, B., Shtil, A., Huezo, H., & Rosen, N. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00253-5 · Cited by 195
Altered states: selectively drugging the Hsp90 cancer chaperone
Workman, P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.005 · Cited by 195
Clarke, P. A., Hostein, I., Banerji, U., Stefano, F. D., Maloney, A., Walton, M., Judson, I., & Workman, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203753 · Cited by 194
Xu, Y., Singer, M. A., & Lindquist, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.109 · Cited by 184
Self-citationMünster, P. N., Marchion, D. C., Basso, A. D., & Rosen, N. X. (2002) · PubMed · Cited by 182
Bisht, K. S., Bradbury, C. M., Mattson, D., Kaushal, A., Sowers, A. L., Markovina, S. S., Ortiz, K. L., Sieck, L., Isaacs, J. S., Brechbiel, M. W., et al. (2003) · PubMed · Cited by 178
Dynamic Remodeling of Transcription Complexes by Molecular Chaperones
Morimoto, R. I. (2002) · Cell · doi:10.1016/s0092-8674(02)00860-7 · Cited by 177
Münster, P. N., Basso, A., Solit, D., Norton, L., & Rosen, N. (2001) · PubMed · Cited by 173
Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers
Rangel, L. B. A., Agarwal, R., Sherman-Baust, C. A., de Mello-Coelho, V., Pizer, E. S., Ji, H., Taub, D. D., & Morin, P. J. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.10.1142 · Cited by 166
Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery
Meyer, P., Prodromou, C., Liao, C., Hu, B., Mark Roe, S., Vaughan, C. K., Vlasic, I., Panaretou, B., Piper, P. W., & Pearl, L. H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600060 · Cited by 166
Disruption of HSP90 Function Reverts Tumor Necrosis Factor-induced Necrosis to Apoptosis
Vanden Berghe, T., Kalai, M., van Loo, G., Declercq, W., & Vandenabeele, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208925200 · Cited by 165
Brugge, J., Yonemoto, W., & Darrow, D. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.1.9 · Cited by 160
Hsp90 Regulates the Activity of Wild Type p53 under Physiological and Elevated Temperatures
Müller, L., Schaupp, A., Walerych, D., Wegele, H., & Büchner, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407687200 · Cited by 157
Hsp90 Chaperones Wild-type p53 Tumor Suppressor Protein
Walerych, D., Kudla, G., Gutkowska, M., Wawrzynów, B., Muller, L., King, F. W., Helwak, A., Boros, J., Żylicz, M., & Żylicz, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407601200 · Cited by 155
High constitutive expression of heat shock protein 90α in human acute leukemia cells
Yufu, Y., Nishimura, J., & Nawata, H. (1992) · Leukemia Research · doi:10.1016/0145-2126(92)90008-u · Cited by 155
Eiseman, J. L., Lan, J. Q., Lagattuta, T. F., Hamburger, D. R., Joseph, E., Covey, J. M., & Egorin, M. J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0865-3 · Cited by 152
Hsp72 Inhibits Apoptosis Upstream of the Mitochondria and Not through Interactions with Apaf-1
Steel, R., Doherty, J. P., Buzzard, K. A., Clemons, N. J., Hawkins, C. J., & Anderson, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401314200 · Cited by 146
Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia
Lu, A., Ran, R., Parmentier‐Batteur, S., Nee, A. C., & Sharp, F. R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00835.x · Cited by 145
Binding of ATP to Heat Shock Protein 90
Garnier, C., Lafitte, D., Tsvetkov, P. O., Barbier, P., Leclerc, J., Millot, J., Briand, C. M., Makarov, A. А., CATELLI, M. G., & Peyrot, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111874200 · Cited by 145
Soga, S., Neckers, L. M., Schulte, T. W., Shiotsu, Y., Akasaka, K., Narumi, H., Agatsuma, T., IKUINA, Y., Murakata, C., Tamaoki, T., et al. (1999) · PubMed · Cited by 133
Egorin, M. J., Zuhowski, E. G., Rosen, D. M., Sentz, D. L., Covey, J. M., & Eiseman, J. L. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000242 · Cited by 133
Rahmani, M., Yu, C., Dai, Y., Reese, E., Ahmed, W. B., Dent, P., & Grant, S. (2003) · PubMed · Cited by 132
Engineered Biosynthesis of Geldanamycin Analogs for Hsp90 Inhibition
Patel, K. G., Piagentini, M., Rascher, A., Tian, Z., Buchanan, G. O., Regentin, R., Hu, Z., Hutchinson, C. R., & McDaniel, R. N. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.09.012 · Cited by 131
Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi, M., Liu, F., Tavorath, R., & Rosen, N. X. (2000) · PubMed · Cited by 126
Genetic Analysis of Viable Hsp90 Alleles Reveals a Critical Role in Drosophila Spermatogenesis
Yue, L., Karr, T. L., Nathan, D. F., Swift, H., Srinivasan, S., & Lindquist, S. L. (1999) · Genetics · doi:10.1093/genetics/151.3.1065 · Cited by 123
Self-citationClinical and biological significance of HSP89 alpha in human breast cancer
Jameel, A., Skilton, R. A., Campbell, T., Chander, S. K., Coombes, R. C., & Luqmani, Y. A. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500315 · Cited by 119
Expression and Roles of Heat Shock Proteins in Human Breast Cancer
Yano, M., Naito, Z., Tanaka, S., & Asano, G. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02119.x · Cited by 116
Sepehrnia, B., Paz, I. B., Dasgupta, G., & Momand, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15084 · Cited by 116
Santarosa, M., Favaro, D., Quaia, M., & Galligioni, E. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00002-6 · Cited by 112
Mhaka, A. M., Gady, A. M., Rosen, D. M., Lo, K.-M., Gillies, S. D., & Denmeade, S. R. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.846 · Cited by 105
Prognostic Significance of Heat Shock Proteins HSP70 and HSP90 in Endometrial Carcinomas
Nanbu, K., Konishi, I., Mandai, M., Kuroda, H., Hamid, A. A., Komatsu, T., & Mori, T. (1998) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1998.00069.x · Cited by 104
Analysis of heat‐shock protein expression in myeloid leukaemia cells by flow cytometry
Chant, I., Rose, P. E., & Morris, A. G. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03395.x · Cited by 103
Novobiocin Induces a Distinct Conformation of Hsp90 and Alters Hsp90−Cochaperone−Client Interactions
Yun, B.-G., Huang, W., Leach, N., Hartson, S. D., & Matts, R. L. (2004) · Biochemistry · doi:10.1021/bi0497998 · Cited by 102
Independent ATPase Activity of Hsp90 Subunits Creates a Flexible Assembly Platform
McLaughlin, S. H., Ventouras, L.-A., Lobbezoo, B., & Jackson, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.055 · Cited by 102
Development of a Fluorescence Polarization Assay for the Molecular Chaperone Hsp90
Kim, J., Felts, S. J., Llauger, L., He, H., Huezo, H., Rosen, N. X., & Chiosis, G. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265995 · Cited by 101
Heat Shock Response - Pathophysiological Implications
Leppä, S., & Sistonen, L. (1997) · Annals of Medicine · doi:10.3109/07853899708998745 · Cited by 101
Sliutz, G., Karlseder, J., Tempfer, C. M., Orel, L., Holzer, G., & Simon, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.334 · Cited by 98
Grammatikakis, N., Vultur, A., Ramana, C. V., Siganou, A., Schweinfest, C. W., Watson, D. K., & Raptis, L. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109200200 · Cited by 97
Bonvini, P., Rosa, H. D., Vignes, N., & Rosolen, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3531 · Cited by 92
17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models
Burger, A. M., Fiebig, H., Stinson, S. F., & Sausville, E. A. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200404000-00011 · Cited by 89
Zeng, Y., Feng, H., Graner, M. W., & Katsanis, E. (2003) · Blood · doi:10.1182/blood-2002-10-3108 · Cited by 87
Ralhan, R., & Kaur, J. (1995) · PubMed · Cited by 87
Huai, Q., Wang, H., Liu, Y., Kim, H.-Y., Toft, D. O., & Ke, H. (2005) · Structure · doi:10.1016/j.str.2004.12.018 · Cited by 86
Beliakoff, J., Bagatell, R., Paine-Murrieta, G. D., Taylor, C. W., Lykkesfeldt, A. E., & Whitesell, L. J. (2003) · PubMed · Cited by 85
Self-citationA novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90
Itoh, H., Ogura, M., Komatsuda, A., Wakui, H., MIURA, A. B., & Tashima, Y. (1999) · Biochemical Journal · doi:10.1042/bj3430697 · Cited by 83
Synthesis and evaluation of geldanamycin–testosterone hybrids
Kuduk, S. D., Harris, C. R., Zheng, F. F., Sepp‐Lorenzino, L., Ouerfelli, O., Rosen, N. X., & Danishefsky, S. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00208-0 · Cited by 82
Bagatell, R., Beliakoff, J., David, C. L., Marron, M. T., & Whitesell, L. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20611 · Cited by 81
Self-citationZheng, F. F., Kuduk, S. D., Chiosis, G., Münster, P. N., Sepp‐Lorenzino, L., Danishefsky, S. J., & Rosen, N. X. (2000) · PubMed · Cited by 81
Waddington’s widget: Hsp90 and the inheritance of acquired characters
Ruden, D. M., Garfinkel, M. D., Sollars, V. E., & Lu, X. (2003) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.09.024 · Cited by 77
Kimura, E., Enns, R. E., Alcaraz, J. E., Arboleda, J., Slamon, D. J., & Howell, S. B. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.5.891 · Cited by 71
Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells
Nomura, M., Nomura, N., Newcomb, E. W., Lukyanov, Y., Tamasdan, C., & Zagzag, D. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20090 · Cited by 69
Dymock, B. W., Barril, X., Beswick, M., Collier, A. J., Davies, N., Drysdale, M., Fink, A., Fromont, C., Hubbard, R. E., Massey, A. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.011 · Cited by 68
Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients.
Conroy, S. E., Sasieni, P. D., Is, F., & Latchman, D. S. (1998) · PubMed · Cited by 67
Enmon, R. M., Yang, W.-H., Ballangrud, Å., Solit, D. B., Heller, G., Rosen, N. X., Scher, H. I., & Sgouros, G. (2003) · PubMed · Cited by 66
The Heat Shock Protein 90-Targeting Drug Cisplatin Selectively Inhibits Steroid Receptor Activation
Rosenhagen, M. C., Sőti, C., Schmidt, U., Wochnik, G. M., Hartl, F. U., Holsboer, F., Young, J. C., & Rein, T. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0141 · Cited by 62
Heat Shock Proteins and Their Use as Anticancer Vaccines
Parmiani, G., Testori, A., Maio, M., Castelli, C., Rivoltini, L., Pilla, L., Belli, F., Mazzaferro, V., Coppa, J. C., Patuzzo, R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1194 · Cited by 60
Differential expression of 70–kDa heat shock‐protein in human oral tumorigenesis
Kaur, J., & Ralhan, R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630604 · Cited by 60
Sausville, E. A. (2001) · PubMed · Cited by 56
Genes and Proteins Governing the Cellular Sensitivity to HSP90 Inhibitors: A Mechanistic Perspective
Maloney, A., Clarke, P. A., & Workman, P. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481822 · Cited by 53
Oncogenic Mutations Reduce the Stability of Src Kinase
Falsone, S. F., Leptihn, S., Osterauer, A., Haslbeck, M., & Büchner, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.091 · Cited by 51
Trieb, K., Gerth, R., Holzer, G., Grohs, J. G., Berger, P., & Kotz, R. I. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0881 · Cited by 48
Inhibitors of HSP90 and other chaperones for the treatment of cancer
Dymock, B. W., Drysdale, M. J., McDonald, E., & Workman, P. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.6.837 · Cited by 46
Vasilevskaya, I. A., Rakitina, T. V., & O'Dwyer, P. J. (2003) · PubMed · Cited by 45
Novel biologically based therapies for Waldenstrom's macroglobulinemia
Mitsiades, C. S., Mitsiades, N., Richardson, P. G. G., Treon, S. P., & Anderson, K. C. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50065 · Cited by 43
Lee, Y. S., Marcu, M. G., & Neckers, L. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.05.010 · Cited by 35
Turbyville, T. J., Wijeratne, E. M. K., Whitesell, L. J., & Gunatilaka, A. A. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0050 · Cited by 29
Self-citationHsp90 and Chromatin: Where is the Link?
Sangster, T. A., Queitsch, C., & Lindquist, S. L. (2003) · Cell Cycle · doi:10.4161/cc.2.3.400 · Cited by 29
Self-citationCell-cycle arrests and p53 accumulation induced by geldanamycin in human ovarian tumour cells
McIlwrath, A. J., Brunton, V. G., & Brown, R. E. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050407 · Cited by 25
Research works printed but not linked: 2
- McCollum, A., Toft, D. O. & Erlichman, C. Geldanamycin enhances cisplatin cytotoxicity through loss of Akt activation in A549 cells. Clin. Cancer Res. 9 (Suppl.), 6178 (2003).
- Barbosa, J. A. et al. Discovery of novel small molecule Hsp90 complex inhibitors using a forward chemical genetics approach. Clin. Cancer Res. 9 (Suppl.), 6176 (2003).
Cited by
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Self-citationPrinciples of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Metadata
- Authors
- Whitesell, L., & Lindquist, S. L.
- Affiliations
- University of Arizona (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Whitesell, Luke
- ORCID
- Whitesell, Luke
- Venue
- Nature Reviews Cancer
- Published
- 2005-09-20
- Volume
- 5
- Issue
- 10
- Pages
- 761-772
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2022531767
- Cited by
- 2,502
- References
- 149
- Citations by year
- 2026: 81 · 2025: 87 · 2024: 83 · 2023: 97 · 2022: 90 · 2021: 113 · 2020: 123 · 2019: 142 · 2018: 99 · 2017: 116 · 2016: 126 · 2015: 152 · 2014: 154 · 2013: 153 · 2012: 167
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- HSP90, molecular chaperones, carcinogenesis, malignant transformation, somatic evolution, protein folding, proteome, anticancer drug targets, chaperone inhibition
- MeSH terms
- Animals, Humans, Neoplasms, Molecular Chaperones, HSP90 Heat-Shock Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.